ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Serelaxin Decreases the Severity of Cold Ischemia-Reperfusion Injury After Liver Transplantation in Mice.

S. Kageyama, K. Nakamura, R. Busuttil, J. Kupiec-Weglinski.

The Dumont-UCLA Transplantation Center, UCLA, Los Angeles, CA.

Meeting: 2016 American Transplant Congress

Abstract number: 397

Keywords: Donors, Ischemia, Liver preservation, Liver transplantation, marginal

Session Information

Date: Tuesday, June 14, 2016

Session Name: Concurrent Session: Ischemic Injury and Organ Preservation: Animal Models

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:42pm-3:54pm

Location: Room 313

Related Abstracts
  • Mesenchymal Stem Cells Reprogram Macrophage Polarization and Attenuate Liver Ischemia and Reperfusion Injury by Regulating Notch/Cox2/PGE2 Signaling Pathway.
  • HO-1/SIRT1/p53 Axis Regulates Macrophage Activation and Attenuates Liver Ischemia-Reperfusion Injury in Mice.

Background. Extended cold preservation contributes to ischemia-reperfusion injury (IRI), which impairs graft function and leads to poor clinical outcomes. Serelaxin (SER), a recombinant form of a human hormone relaxin, promotes cardioprotection and ameliorates IRI in experimental cardiac models. Phase III clinical trials are underway to evaluate the efficacy of SER in acute heart failure. No data exists as to whether/how SER may influence innate immune activation and inflammatory responses in liver transplant recipients. We have recently shown that heme oxygenase-1 (HO-1) activated macrophage Notch1/Hes1/Stat3/Akt signaling is instrumental in liver resistance against IRI by reprogramming macrophages toward the M2 phenotype and inducing anti-apoptotic proteins. Aim. This study was designed to determine the effects of SER upon IRI pathology in mouse orthotopic liver transplantation (OLT) and in vitro in bone marrow-derived macrophage (BMM) cultures. Methods. Male C57BL/6 mouse livers, preserved for 20h at 4[deg] in UW solution, were transplanted orthotopically to syngeneic mice (C57BL/6). A SER bolus was given at reperfusion (5ug/kg via portal vein) and OLT were harvested at 6h of reperfusion. The effects of SER (5[mu]g/ml) were also studied in LPS (100ng/ml) or IL-4 (10ng/ml) stimulated BMM cultures.

Results. Donor liver conditioning with SER (at time of reperfusion) significantly decreased sALT levels in OLT recipients (3,499±668 vs. 7,125±1018 IU/L; n=5/gr; p<0.05); and ameliorated IR-mediated hepatocellular damage, assessed by histology (Suzuki's score: 1.8±0.5 vs. 5.0±0.8; n=5/gr; p<0.05) as compared with controls. In LPS-stimulated BMM cultures, SER increased protein levels of Notch1, Hes1, p-Stat3, Arg-1, p-Akt, Bcl-xL, Bcl-2 and decreased p-IkBa (Western analyses). In parallel, SER decreased mRNA levels coding for IL-1β, CXCL-10, MCP1, CCL-5 and IL-12 while Arg-1 expression sharply increased after LPS stimulation (RT-PCR, p<0.05). Consistently, after IL-4 stimulation, SER increased protein levels of Notch1, Hes1, p-Stat3 and mRNA levels of Arg-1, CD163, CCL-24, IL-10, c-Myc (p<0.05). However, SER did not affect HO-1 expression in LPS or IL-4 stimulated BMM cultures. Conclusion. This study is the first to document the efficacy of SER against hepatic IRI in mouse orthotopic liver transplantation. SER attenuated macrophage activation and reduced IR-hepatocellular damage by activating Notch1 signaling independent from anti-oxidant HO-1 pathway.

CITATION INFORMATION: Kageyama S, Nakamura K, Busuttil R, Kupiec-Weglinski J. Serelaxin Decreases the Severity of Cold Ischemia-Reperfusion Injury After Liver Transplantation in Mice. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kageyama S, Nakamura K, Busuttil R, Kupiec-Weglinski J. Serelaxin Decreases the Severity of Cold Ischemia-Reperfusion Injury After Liver Transplantation in Mice. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/serelaxin-decreases-the-severity-of-cold-ischemia-reperfusion-injury-after-liver-transplantation-in-mice/. Accessed March 4, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.